Microcurrent Stimulation for Age-Related Macular Degeneration
What You Need to Know Before You Apply
What is the purpose of this trial?
Age-related macular degeneration (AMD) is an eye condition that affects the retina and can lead to progressive vision loss. This study will evaluate the effects of MacuMira microcurrent stimulation on dark adaptation in adults with intermediate dry AMD.
Participants will receive four in-office treatment sessions over 10 to 14 days. Dark adaptation and other measures of visual function and retinal health will be assessed before treatment and at one and three months after treatment.
Are You a Good Fit for This Trial?
This trial is for adults with intermediate dry age-related macular degeneration (AMD), a condition that affects the retina and can cause vision loss. Participants should not have other major eye diseases or conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Transpalpebral microcurrent electrical stimulation
Trial Overview
The study tests MacuMira microcurrent stimulation, a gentle electrical treatment applied to the eyelids, given in four sessions over about two weeks. The goal is to see if it improves night vision and retinal health in people with dry AMD.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participants will receive four in-office sessions of transpalpebral microcurrent electrical stimulation using the MacuMira device over approximately 10 to 14 days.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Clarity Eye Institute
Lead Sponsor
MacuMira
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.